Cell Line Development Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Aug 2021
  • Pages: 120
  • SKU: IRTNTR70857
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The cell line development market has the potential to grow by $ 4.39 bn during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 13.17%.

This cell line development market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by Product (Media and reagents and Equipment) and Geography (North America, Europe, Asia, and ROW). The cell line development market report also offers information on several market vendors, including Cobra Biologics Ltd., Danaher Corp., Lonza Group Ltd., Merck KGaA, Molecular Devices LLC, Promega Corp., Sartorius AG, Selexis SA, Thermo Fisher Scientific Inc., and WuXi Biologics (Cayman) Inc. among others.

What will the Cell Line Development Market Size be in 2021?

Cell-Line-Development-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of Cell Line Development Market

 Get Your FREE Sample Now!

Cell Line Development Market: Key Drivers and Trends

Based on our research output, there has been a NEUTRAL impact on the market growth during and post COVID-19 era. The increased demand for monoclonal antibodies is notably driving the cell line development market growth, although factors such as high risk of contamination may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cell line development market industry. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.

This cell line development market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Cell Line Development Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

  • Cobra Biologics Ltd.
  • Danaher Corp.
  • Lonza Group Ltd.
  • Merck KGaA
  • Molecular Devices LLC
  • Promega Corp.
  • Sartorius AG
  • Selexis SA
  • Thermo Fisher Scientific Inc.
  • WuXi Biologics (Cayman) Inc.

The vendor landscape of the cell line development market entails successful business strategies deployed by the vendors. The cell line development market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the cell line development market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Cell Line Development Market?

Cell-Line-Development-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

35% of the market’s growth will originate from North America during the forecast period. US, China, Japan, Canada, and Germany are the key markets for cell line development market in North America. 

The report offers an up-to-date analysis of the geographical composition of the market. North America has been recording significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. Patent expiration of drugs will facilitate the cell line development market growth in North America over the forecast period. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.

What are the Revenue-generating Product Segments in the Cell Line Development Market?

Cell-Line-Development-Market-Market-Share-by-Product-2020-2025

To gain further insights on the market contribution of various segments Request for a FREE sample

The cell line development market share growth by the __ segment has been significant. This report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2021-2025 and embrace technologies to improve business efficiency.

This report provides an accurate prediction of the contribution of all the segments to the growth of the cell line development market size. Furthermore, our analysts have indicated actionable market insights on post COVID-19 impact on each segment, which is crucial to predict change in consumer demand.

Cell Line Development Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 13.17%

Market growth 2021-2025

$ 4.39 billion

Market structure

Fragmented

YoY growth (%)

12.28

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 35%

Key consumer countries

US, China, Japan, Canada, and Germany

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Cobra Biologics Ltd., Danaher Corp., Lonza Group Ltd., Merck KGaA, Molecular Devices LLC, Promega Corp., Sartorius AG, Selexis SA, Thermo Fisher Scientific Inc., and WuXi Biologics (Cayman) Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Cell Line Development Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive cell line development market growth during the next five years
  • Precise estimation of the cell line development market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the cell line development market across North America, Europe, Asia, and ROW 
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of cell line development market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • Media and reagents - Market size and forecast 2020-2025
    • Equipment - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

    • Customer landscape

    Geographic Landscape

    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends

    Vendor Landscape

    • Overview
    • Landscape disruption

    Vendor Analysis

    • Vendors covered
    • Market positioning of vendors
    • Cobra Biologics Ltd.
    • Danaher Corp.
    • Lonza Group Ltd.
    • Merck KGaA
    • Molecular Devices LLC
    • Promega Corp.
    • Sartorius AG
    • Selexis SA
    • Thermo Fisher Scientific Inc.
    • WuXi Biologics (Cayman) Inc.

    Appendix

    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

    Research Framework

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    TechnavioINFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases
    Technavio

    TechnavioDATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts
    Technavio

    TechnavioREPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape
    Interested in this report?
    Get your FREE sample now!
    The cell line development market growth will increase by $4392.04 million during 2020-2025.
    The cell line development market is expected to grow at a CAGR of 13.17% during 2020-2025.
    Technavio has segmented the cell line development market by product (Media and reagent and Equipment) and geographic (North America, Europe, Asia, and ROW).
    Cobra Biologics Ltd., Danaher Corp., Lonza Group Ltd., Merck KGaA, Molecular Devices LLC, Promega Corp., Sartorius AG, Selexis SA, Thermo Fisher Scientific Inc., WuXi Biologics (Cayman) Inc. are a few of the key vendors in the cell line development market.
    North America will register the highest growth rate of 35.47% among the other regions. Therefore, the cell line development market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
    The key factors driving the cell line development market growth are:
    • Increased demand for monoclonal antibodies
    The cell line development market vendors should focus on grabbing business opportunities from the media and reagent segment as it accounted for the largest market share in the base year.
    Safe and Secure SSL Encrypted
    Technavio

    Single User:

    2500 USD

    Technavio Get the report (PDF) sent to your email within minutes.

    Subscribe & Save

    Get lifetime access to our
    Technavio Insights

    Want to customize this report?

    This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

    We offer $1000 worth of FREE customization at the time of purchase
    Technavio
    Enquire Before Buying
    1. Home
    2. Health Care
    3. Published Report
    17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>